 |
FDA Approval Activities for this Drug
020577 CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE INJECTABLE; INTRATHECAL 0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML ELLIOTTS B SOLUTION QOL MEDCL | 019316 MAGNESIUM SULFATE INJECTABLE; INJECTION 500MG/ML MAGNESIUM SULFATE ABRAXIS PHARM | 020488 MAGNESIUM SULFATE INJECTABLE; INJECTION 1GM/100ML MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER HOSPIRA | 020488 MAGNESIUM SULFATE INJECTABLE; INJECTION 2GM/100ML MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER HOSPIRA | 020309 MAGNESIUM SULFATE INJECTABLE; INJECTION 4GM/100ML MAGNESIUM SULFATE IN PLASTIC CONTAINER HOSPIRA | 075151 No MAGNESIUM SULFATE INJECTABLE; INJECTION 500MG/ML MAGNESIUM SULFATE HOSPIRA | 020309 MAGNESIUM SULFATE INJECTABLE; INJECTION 80MG/ML MAGNESIUM SULFATE IN PLASTIC CONTAINER HOSPIRA | 018508 AT No MAGNESIUM SULFATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM PHOSPHATE SOLUTION; IRRIGATION 20MG/100ML;40MG/100ML;6.25MG/100ML;800MG/100ML;8.75MG/100ML TIS-U-SOL BAXTER HLTHCARE | 018336 AT No MAGNESIUM SULFATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM PHOSPHATE SOLUTION; IRRIGATION 20MG/100ML;40MG/100ML;6.25MG/100ML;800MG/100ML;8.75MG/100ML TIS-U-SOL IN PLASTIC CONTAINER BAXTER HLTHCARE | Magnesium Sulfate Injection, Abraxis Pharma, Labeling Revision | Magnesium Sulfate in Water for Injection, Hospira, Inc., Formulation Revision
^ FDA's latest approval appears at the bottom of this list. ^
|